Reviva Pharmaceuticals Holdings RVPH
OTC RVPH
$0.51 +0.02 (+4.08%)
As of: Aug 21, 2026 · 3:48 PM EDT

Reviva Pharmaceuticals Holdings (RVPH) Cash from Investing Activities (2019 - 2020)

Reviva Pharmaceuticals Holdings (RVPH) posted Cash from Investing Activities of -$206122.0 for Q4 2020, up 2.24% sequentially from -$210836.0 in Q3 2020.

Reviva Pharmaceuticals Holdings (RVPH) Cash from Investing Activities (2019 - 2020) Analysis & Trends

Reviva Pharmaceuticals Holdings has reported Cash from Investing Activities for 2 years, with the latest figure at -$206122.0 in Q4 2020.

  • Quarterly Cash from Investing Activities changed N/A year-over-year to -$206122.0 in Q4 2020, while the trailing twelve-month figure through Nov 2020 was $5.7 million (up 108.84% YoY) and the FY2020 annual result came in at $5.7 million, up 108.84% from the prior year.
  • Cash from Investing Activities grew to -$206122.0 in Q4 2020 per RVPH's latest filing, from -$210836.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $26.8 million in Q2 2020 and troughed at -$64.5 million in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 329.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -49.35 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -363.46 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -3.17 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 24.51 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -229.72 Mn
10 Reviva Pharmaceuticals Holdings 6.74 Mn 6.74 Mn - -

Historic Data

Download Data
DateValue
Nov 30, 2020 -206,122.00
Nov 30, 2020 -206,122.00
Aug 31, 2020 -210,836.00
Aug 31, 2020 -210,836.00
May 31, 2020 26.77 Mn
May 31, 2020 26.77 Mn
Feb 29, 2020 -20.65 Mn
Feb 29, 2020 -20.65 Mn
Feb 28, 2019 -64.52 Mn
Feb 28, 2019 -64.52 Mn